Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 38, Issue 5, 2004, Pages

  Antoniou, Tony ^a   Gough, Kevin ^a   Yoong, Deborah ^a   Arbess, Gordon ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE; VALPROIC ACID; ZIDOVUDINE;

ANEMIA; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; TEMPORAL LOBE EPILEPSY;

ANEMIA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIDEOXYNUCLEOSIDES; DRUG INTERACTIONS; EPILEPSY, COMPLEX PARTIAL; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALE; VALPROIC ACID; ZIDOVUDINE;

MLCS; MLOWN;

EID: 10744223995     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/381760     Document Type: Article

References (0)